Management of Xylometazoline Oral Overdose
Contact a Poison Control Center immediately and provide supportive care focused on managing CNS depression and cardiovascular effects, as there is no specific antidote for xylometazoline overdose 1.
Immediate Actions
Contact Poison Control
- Call 1-800-222-1222 in the United States to reach regional poison centers staffed by board-certified toxicologists 2
- In Canada, contact your provincial poison center directly
- These centers provide expert real-time guidance for specific poisoning cases
Supportive Care Framework
Standard resuscitation measures take priority 2:
- Airway management: Assess and secure airway if needed
- Breathing support: Monitor respiratory rate and provide oxygen/ventilation as required
- Cardiovascular monitoring: Watch for bradycardia, hypertension, or hypotension
- CNS assessment: Monitor level of consciousness
Clinical Presentation and Monitoring
Xylometazoline is an alpha-2-adrenergic agonist (imidazoline derivative) that causes:
- CNS depression: Drowsiness, unresponsiveness, altered mental status
- Cardiovascular effects: Bradycardia, supraventricular arrhythmias, blood pressure changes
- Respiratory depression: Decreased respiratory rate requiring oxygen support
Dose-Related Risk Stratification
In children, serious symptoms requiring hospitalization occur in less than 6% of cases when exposure is below 0.4 mg/kg body weight 3. However, even low doses can cause severe intoxication, particularly in young children 3, 4.
Critical case example: Three children exposed to a 40-fold overdose (compounding error) developed unresponsiveness, bradycardia (64 bpm), supraventricular extrasystoles, and respiratory depression requiring oxygen. Recovery took 11-20 hours with supportive care alone—no specific interventions were needed beyond IV fluids and monitoring 4.
Treatment Protocol
No Specific Antidote Exists
Unlike opioid or benzodiazepine overdoses, there is no reversal agent for xylometazoline 2, 4.
Gastrointestinal Decontamination
- Activated charcoal may be considered if presentation is within 1-2 hours of ingestion and airway is protected
- Gastric lavage is NOT routinely recommended and should only be considered in specific life-threatening situations with recent massive ingestion 5
- Syrup of ipecac is NOT recommended 5
Supportive Management
Cardiovascular support:
- Treat bradycardia if symptomatic (atropine may be considered per standard ACLS protocols)
- Monitor for arrhythmias continuously
- Manage blood pressure abnormalities with standard vasopressors or antihypertensives as needed
Respiratory support:
- Provide supplemental oxygen for hypoxemia
- Prepare for intubation if respiratory depression worsens or airway reflexes are lost
- Monitor oxygen saturation and respiratory rate closely
Fluid management:
- Establish IV access
- Provide maintenance fluids
Observation Period
- Hospital observation is recommended even for seemingly minor exposures, especially in children under 6 years 3
- Monitor for at least 6-8 hours; symptoms may persist for 11-20 hours in significant overdoses 4
- Watch for delayed CNS or cardiovascular deterioration
Common Pitfalls to Avoid
- Do not assume low doses are safe: Even small amounts can cause severe symptoms in children 3, 4
- Do not delay Poison Control consultation: Expert guidance is readily available and should be utilized 2
- Do not use gastric lavage routinely: Reserved only for massive, recent ingestions 5
- Do not discharge too early: Symptoms can be prolonged; ensure adequate observation period 4
- Be aware of compounding errors: Verify concentration if overdose seems disproportionate to reported dose 4
Key Differences from Similar Agents
While xylometazoline and oxymetazoline are both imidazoline derivatives with similar mechanisms, the evidence base is stronger for xylometazoline toxicity in children. One case report describes cardiac arrest and myocardial infarction from oxymetazoline overdose in an adult 6, highlighting that severe cardiovascular complications are possible with this drug class.